These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 6956488)
21. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists. Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176 [TBL] [Abstract][Full Text] [Related]
23. Comparative effects of selected antifolates on transforming human lymphocytes and on established human lymphoblastic cell lines. Hoffmann CC; Ho YK; Blakley RL; Thompson JS Biochem Pharmacol; 1976 Sep; 25(17):1947-54. PubMed ID: 985532 [No Abstract] [Full Text] [Related]
24. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells. Chen G; Wright JE; Rosowsky A Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904 [TBL] [Abstract][Full Text] [Related]
25. Dissociation of thymidylate biosynthesis from DNA biosynthesis by 5-fluoro-2'-deoxyuridine and 5,8-dideazaisofolic acid. Fernandes DJ; Cranford SK Cancer Res; 1986 Apr; 46(4 Pt 1):1741-7. PubMed ID: 2936450 [TBL] [Abstract][Full Text] [Related]
26. Antitumor activity of antifolate inhibitors of thymidylate and purine synthesis in human soft tissue sarcoma cell lines with intrinsic resistance to methotrexate. Li WW; Tong WP; Bertino JR Clin Cancer Res; 1995 Jun; 1(6):631-6. PubMed ID: 9816025 [TBL] [Abstract][Full Text] [Related]
27. Flow cytometric characterization of antifolate resistance in cultured mammalian cells using fluoresceinated methotrexate and daunorubicin. Sherwood SW; Assaraf YG; Molina A; Schimke RT Cancer Res; 1990 Aug; 50(16):4946-50. PubMed ID: 2143099 [TBL] [Abstract][Full Text] [Related]
28. Recombinant tumor necrosis factor alpha inhibits growth of methylcholanthrene-induced sarcoma and enhances natural killer activity of tumor-infiltrating lymphocytes in aging rats. Ziółkowska M; Nowak JJ; Janiak M; Ryzewska A Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):357-64. PubMed ID: 8010877 [TBL] [Abstract][Full Text] [Related]
29. A comparison of the effects of nine folate analogs on early and late murine hematopoietic progenitor cells in vitro. Strømhaug A; Warren DJ Cancer Chemother Pharmacol; 2000; 45(6):450-6. PubMed ID: 10854131 [TBL] [Abstract][Full Text] [Related]
30. Suppression of B cell function by methotrexate and trimetrexate. Evidence for inhibition of purine biosynthesis as a major mechanism of action. Rosenthal GJ; Weigand GW; Germolec DR; Blank JA; Luster MI J Immunol; 1988 Jul; 141(2):410-6. PubMed ID: 2968399 [TBL] [Abstract][Full Text] [Related]
31. The influence of methotrexate and thymidine on the human natural killer cell function in vitro. Matheson DS; Green B; Hoar DI J Immunol; 1983 Oct; 131(4):1619-21. PubMed ID: 6619541 [No Abstract] [Full Text] [Related]
32. Inhibition of dihydrofolate reductase and cell growth by antifolates in a methotrexate-resistant cell line. Hamrell MR Oncology; 1984; 41(5):343-8. PubMed ID: 6540852 [TBL] [Abstract][Full Text] [Related]
33. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines. Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632 [TBL] [Abstract][Full Text] [Related]
34. Manifestation and growth of a transplantable osteosarcoma in mice: the effects of thymectomy and thymosin treatment. Carlsson SR; Stigbrand T; Boquist L; Lundgren E; Winblad B; Larsson SE Clin Orthop Relat Res; 1981 Sep; (159):279-85. PubMed ID: 6974629 [TBL] [Abstract][Full Text] [Related]
35. The impact of p53 status on cellular sensitivity to antifolate drugs. Lu X; Errington J; Curtin NJ; Lunec J; Newell DR Clin Cancer Res; 2001 Jul; 7(7):2114-23. PubMed ID: 11448931 [TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells. Smith SG; Lehman NL; Moran RG Cancer Res; 1993 Dec; 53(23):5697-706. PubMed ID: 8242626 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of DNA synthesis in normal and malignant human cells by triazinate (Baker's antifol) and methotrexate. Skeel RT; Sawicki WL; Cashmore AR; Bertino JR Cancer Res; 1976 Oct; 36(10):3659-64. PubMed ID: 953990 [TBL] [Abstract][Full Text] [Related]
38. A model for human osteosarcoma in hamsters. Singh I; Tsang KY; Blakemore WS Clin Orthop Relat Res; 1979 Oct; (144):305-10. PubMed ID: 294956 [TBL] [Abstract][Full Text] [Related]
39. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists. Chello PL; McQueen CA; DeAngelis LM; Bertino JR Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151 [TBL] [Abstract][Full Text] [Related]
40. Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates. Chung KN; Saikawa Y; Paik TH; Dixon KH; Mulligan T; Cowan KH; Elwood PC J Clin Invest; 1993 Apr; 91(4):1289-94. PubMed ID: 7682567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]